Golden Biotechnology Corporation acquires patent in the U.S. for the treatment of neurodegenerative diseases and patent in Japan for the treatment of arteriosclerosis diseases
Golden Biotechnology Corporation (GBC) is an international company based in Taiwan that has been dedicated to manufacturing natural products that improve human health by preventing and curing pathologies since 2002. It recently acquired a patent in the United States to treat neurodegenerative diseases and another patent in Japan to treat arteriosclerosis.
Patent in the United States
The Patent and Trademark Office in the United States approved a patent for the drug Antroquinonol, which is included in the “Methods and Compositions for the Treatment of Neurodegenerative Diseases...”
